NCT07147231
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07147231
Title Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
MedStar Georgetown University Hospital RECRUITING Washington D.C. District of Columbia 20007 United States Details
Emory University Hospital Midtown RECRUITING Atlanta Georgia 30308 United States Details
Emory University Hospital/Winship Cancer Institute RECRUITING Atlanta Georgia 30322 United States Details
Emory Saint Joseph's Hospital RECRUITING Atlanta Georgia 30342 United States Details
University of Maryland/Greenebaum Cancer Center RECRUITING Baltimore Maryland 21201 United States Details
Johns Hopkins University/Sidney Kimmel Cancer Center RECRUITING Baltimore Maryland 21287 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field